Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome.

医学 肺动脉高压 内科学 心脏病学 艾森曼格综合征 血流动力学 肺动脉
作者
William E. Hopkins,Laura Ochoa,G. W. Richardson,E.R.Losada Trulock
出处
期刊:PubMed 卷期号:15 (1 Pt 1): 100-5 被引量:143
链接
标识
摘要

To date, lung or heart-lung transplantation remains the only definitive treatment for most adults with severe primary pulmonary hypertension or Eisenmenger syndrome. Although the hemodynamic derangements and clinical history of adults with severe primary pulmonary hypertension have been well documented, those of adults with Eisenmenger syndrome have not.We evaluated hemodynamics and nontransplantation survival of 100 adults with severe pulmonary hypertension (34 +/- 9 years, 73 women and 27 men; 57 with primary pulmonary hypertension, 37 with Eisenmenger syndrome, and six with a previously repaired congenital heart defect) followed up by the lung transplant or adult congenital heart services at Washington University.Despite a trend toward greater pulmonary artery pressures (107 +/- 20 versus 97 +/- 21 mm Hg, p = 0.06), patients with Eisenmenger syndrome had greater systemic cardiac indexes (2.7 +/- 0.6 versus 2.2 +/- 0.8 L/min/m2, p < 0.05) and lower mean right atrial pressures (5 +/- 2 versus 12 +/- 5 mm Hg, p < 0.0001) than patients with primary pulmonary hypertension. Four (11%) patients with Eisenmenger syndrome died and eight (22%) received transplants during the follow-up interval; 13 (23%) patients with primary pulmonary hypertension died, and 31 (54%) received transplants over the same interval. Actuarial survival of patients who did not receive transplants was 97% at 1 year, 89% at 2 years, and 77% at 3 years for patients with Eisenmenger syndrome and 77%, 69%, and 35%, respectively, for patients with primary pulmonary hypertension. Data on hemodynamics from a small number of patients with a previously repaired heart defect and severe pulmonary hypertension were similar to those from patients with primary pulmonary hypertension.Our data suggest that adults with Eisenmenger syndrome have a more favorable hemodynamic profile and prognosis than adults with primary pulmonary hypertension.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
杨二锤完成签到 ,获得积分10
1秒前
zpz发布了新的文献求助10
1秒前
领导范儿应助DARKNESS采纳,获得10
1秒前
1秒前
1秒前
xxl发布了新的文献求助10
2秒前
善学以致用应助春山采纳,获得10
2秒前
WZQ发布了新的文献求助10
2秒前
2秒前
香蕉觅云应助高高的世德采纳,获得10
3秒前
高高应助jiejie采纳,获得10
3秒前
3秒前
3秒前
梦梦发布了新的文献求助10
3秒前
咯咯葛完成签到,获得积分10
4秒前
科研通AI2S应助快乐的晟睿采纳,获得10
4秒前
4秒前
chen完成签到,获得积分10
4秒前
舒适悒完成签到,获得积分10
5秒前
Jonah发布了新的文献求助10
6秒前
17852573662完成签到,获得积分10
6秒前
6秒前
小机灵鬼儿完成签到,获得积分10
6秒前
sun应助doukeze采纳,获得20
6秒前
舒心谷雪完成签到 ,获得积分10
7秒前
汉堡包应助Junior采纳,获得10
7秒前
科研通AI5应助侠客采纳,获得10
7秒前
Skye完成签到,获得积分10
7秒前
AAAaa发布了新的文献求助10
7秒前
MSG发布了新的文献求助10
7秒前
8秒前
8秒前
悦子完成签到,获得积分10
8秒前
xxl完成签到,获得积分10
9秒前
kingwill发布了新的文献求助20
9秒前
miluren发布了新的文献求助10
9秒前
舒适悒发布了新的文献求助10
9秒前
9秒前
10秒前
小艾艾麦仑完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
F-35B V2.0 How to build Kitty Hawk's F-35B Version 2.0 Model 2000
줄기세포 생물학 1000
Biodegradable Embolic Microspheres Market Insights 888
Quantum reference frames : from quantum information to spacetime 888
2025-2031全球及中国蛋黄lgY抗体行业研究及十五五规划分析报告(2025-2031 Global and China Chicken lgY Antibody Industry Research and 15th Five Year Plan Analysis Report) 400
La RSE en pratique 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4463162
求助须知:如何正确求助?哪些是违规求助? 3925999
关于积分的说明 12183055
捐赠科研通 3578605
什么是DOI,文献DOI怎么找? 1966036
邀请新用户注册赠送积分活动 1004781
科研通“疑难数据库(出版商)”最低求助积分说明 899141